lundi 13 juillet 2015

Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes

Aucun commentaire:

Enregistrer un commentaire